Dacikast 60 Mg Tablets

Dacikast 60mg (Daclatasvir) is an inhibitor of non-structural protein 5A (NS5A). Each film-coated tablet contains Daclatasvir Dihydrochloride equivalent to Daclatasvir 30 mg or 60mg.

INDICATIONS AND USAGE

Dacikast is indicated in combination with Sofosbuvir for the treatment of patient with chronic hepatitis C virus (HCV) genotype 3 infection.

Dacikast 30 mg tablets are available in bottle pack of 28 tablets. Dacikast 60 mg tablets are available in bottle pack of 28 tablets. Store below 25°C.

Dacikast Tablets  is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.

• Keep all medicines out of the reach of children and away from pets, never share your medicines with others, and use this medication only for the indication prescribed.

• The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Notice: The above information is an educational aid only. It is not intended as medical advice for individual conditions or treatments. Talk to your doctor, nurse or pharmacist before following any medical regimen to see if it is safe and effective for you.

Before eating/consuming any medicine kindly do consult with your doctor / Medical adviser / Nurse / Hospital /medicine Institution / Health advisor or pharmacist/ medicine healer.

Do not indulge in self medication using internet information.

Self medication can be dangerous.